Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response.
Adams A, Gupta V, Mohsen W, Chapman TP, Subhaharan D, Kakkadasam Ramaswamy P, Kumar S, Kedia S, McGregor CG, Ambrose T, George BD, Palmer R, Brain O, Walsh A, Ahuja V, Travis SPL, Satsangi J. Adams A, et al. Among authors: mcgregor cg. Gut. 2023 Mar;72(3):433-442. doi: 10.1136/gutjnl-2022-327533. Epub 2022 Sep 28. Gut. 2023. PMID: 36171080
Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic.
McGregor CG, Adams A, Sadler R, Arancibia-Cárcamo CV, Palmer R, Ambrose T, Brain O, Walsh A, Klenerman P, Travis SP, Croft NM, Lindsay JO, Satsangi J. McGregor CG, et al. Gut. 2021 Dec;70(12):2398-2400. doi: 10.1136/gutjnl-2021-324116. Epub 2021 Feb 12. Gut. 2021. PMID: 33579788 No abstract available.
Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease.
Wellens J, Edmans M, Obolski U, McGregor CG, Simmonds P, Turner M, Jarvis L, Skelly D, Dunachie S, Barnes E, Eyre DW, Colombel JF, Wong SY, Klenerman P, Lindsay JO, Satsangi J, Thompson CP. Wellens J, et al. Among authors: mcgregor cg. Gut. 2022 Sep;71(9):1919-1922. doi: 10.1136/gutjnl-2021-326312. Epub 2021 Dec 15. Gut. 2022. PMID: 34911744 No abstract available.
Geography Influences Susceptibility to SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease: Multinational Analysis From the ICARUS-IBD Consortium.
Wong SY, Wellens J, Helmus D, Marlow L, Brann S, Martinez Pazos V, Weinberg A, Moran HR, McGregor C, Vermeire S, Watanabe K, Kamikozuru K, Ahuja V, Vermani S, Lindsay JO, Kingston A, Dutta U, Kaur H, Silverberg MS, Milgrom R, Chien Ng S, Mak JWY, Cadwell K, Thompson C, Colombel JF, Satsangi J; ICARUS-IBD Consortium. Wong SY, et al. Inflamm Bowel Dis. 2023 Nov 2;29(11):1693-1705. doi: 10.1093/ibd/izad097. Inflamm Bowel Dis. 2023. PMID: 37354560
Pathogenesis of Fistulating Crohn's Disease: A Review.
McGregor CGC, Tandon R, Simmons A. McGregor CGC, et al. Cell Mol Gastroenterol Hepatol. 2023;15(1):1-11. doi: 10.1016/j.jcmgh.2022.09.011. Epub 2022 Sep 29. Cell Mol Gastroenterol Hepatol. 2023. PMID: 36184031 Free PMC article. Review.
Proteomic Analysis of the Myocardium in Hypertrophic Obstructive Cardiomyopathy.
Coats CJ, Heywood WE, Virasami A, Ashrafi N, Syrris P, Dos Remedios C, Treibel TA, Moon JC, Lopes LR, McGregor CGA, Ashworth M, Sebire NJ, McKenna WJ, Mills K, Elliott PM. Coats CJ, et al. Among authors: mcgregor cga. Circ Genom Precis Med. 2018 Dec;11(12):e001974. doi: 10.1161/CIRCGEN.117.001974. Circ Genom Precis Med. 2018. PMID: 30562113
269 results